The lower relapse rate and better survival advantages of haploidentical allograft compared with HLA-matched sibling donor allografts for intermediate- and adverse-risk AML patients with pretransplantation minimal residual disease.
Ming WangBixia WangLan-Ping XuYu WangXiao-Hui ZhangYi-Fei ChengYu-Qian SunYuan-Yuan ZhangYan-Rong LiuYing-Jun ChangKai-Yan LiuXiao-Jun HuangPublished in: Bone marrow transplantation (2022)